## Abstract The most important problem in the therapy of patients with acute myeloid leukemia (AML) is relapse after intensive therapy. We sought to determine if interleukinβ2 (lowβdose with intermittent boluses) administration could be feasibly administered after standard therapy to potentiate ant
Subacute pulmonary failure complicating therapy with high-dose ara-C in acute leukemia
β Scribed by Borje S. Andersson; Brad M. Cogan; Michael J. Keating; Elihu H. Estey; Kenneth B. McCredie; Emil J Freireich
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 413 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Rebleeding from peptic ulcers is a major contributor to death. This study compared standard (40-mg intravenous infusion of omeprazole once daily for 3 days) and high-dose (80-mg bolus of omeprazole followed by 8-mg/h infusion for 72 h) in reducing the rebleeding rate (pri
## Background: In the current study, the authors evaluated late neuropsychologic effects 7 years after diagnosis and the long-term survival in a cohort of patients treated for high-risk childhood acute lymphoblastic leukemia (all) with cranial radiation therapy. efficacy and toxicity were evaluated